Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

[...]of an error in the production process, a duplicate of Figure 5 appears in place of Figure 4. Figures Citation: Moore AR, Boyce M, Steele IA, Campbell F, Varro A, Pritchard DM (2013) Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2013-11, Vol.8 (11)
Hauptverfasser: Moore, Andrew R., Boyce, Malcolm, Steele, Islay A., Campbell, Fiona, Varro, Andrea, Pritchard, D. Mark
Format: Artikel
Sprache:eng
Schlagworte:
Biomarkers
Gastrin
Gastritis
Neuroendocrine tumors
Tumors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]of an error in the production process, a duplicate of Figure 5 appears in place of Figure 4. Figures Citation: Moore AR, Boyce M, Steele IA, Campbell F, Varro A, Pritchard DM (2013) Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis.
ISSN:1932-6203
1932-6203
DOI:10.1371/annotation/4afd48b1-8dc0-47cc-9c8a-99aba7623116